Wave Life Sciences has appointed Christian Henry to its board of directors and as chair of its audit committee. Henry has held a variety of executive level positions at Illumina, including CFO, general manager of life sciences, general manager of genomic solutions, and most recently chief commercial officer. Prior to joining Illumina, he served as CFO of Tickets.com. He has also served as vice president of finance and corporate controller of Affymetrix, and has held various positions at Nektar Therapeutics, Sugen, and Ernst & Young.
Genos Strategic Advisory Board
Genos has appointed George Church, Mina Radhakrishan, Alvin Roth, Dietrich Stephan, and Chris Tsakalakis to its strategic advisory board. Church is currently a professor of genetics at Harvard Medical School, director of the Center for Computational Genetics, founder of PersonalGenomes.org, and a founding core member of the Wyss Institute. Radhakrishan was the former head of product at Uber and a current startup advisor. She is also currently an entrepreneur-in-residence at Redpoint Ventures, special advisor at Cowboy Ventures, and a mentor to companies in the 500 Startups portfolio. Roth is a professor of economics at Stanford University and a 2012 Nobel Prize winner. Stephan is the chair of the department of human genetics at the University of Pittsburgh, founding chairman of the neurogenomics department at the Translational Genomics Research Institute, and founder of Navigenics. Tsakalakis is currently an entrepreneur-in-residence at Benchmark Capital, and previously served as president of StubHub.
BioMérieux has appointed Pierre Boulud to the position of Corporate VP for the Asia Pacific region. He joins the company's executive committee and will report directly to CEO Alexandre Mérieux. Boulud will also oversee BioMérieux's portfolio and strategic planning starting on Jan. 1. Before joining BioMérieux, Boulud worked for 14 years at Ipsen, where he held various positions, including head of the strategy and business development and executive vice president of specialty care commercial operations. Before he joined Ipsen, he worked at the Boston Consulting Group where he oversaw strategic consulting assignments.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.